We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

116 hedge funds and large institutions have $156M invested in Precision BioSciences in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 23 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 23

79% more call options, than puts

Call options by funds: $334K | Put options by funds: $187K

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

1% more funds holding

Funds holding: 115 → 116 (+1)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% less ownership

Funds ownership: 1.63% → 1.63% (-0%)

26% less capital invested

Capital invested by funds: $211M → $156M (-$54.5M)

Holders
116
Holders Change
+1
Holders Change %
+0.87%
% of All Funds
2.34%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
18
Increased
42
Reduced
23
Closed
17
Calls
$334K
Puts
$187K
Net Calls
+$147K
Net Calls Change
+$504K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.99M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.05M
3
IHAM
Integral Health Asset Management
New York
+$1.99M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.69M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.38M

Top Sellers

Rank Fund Capital Flow
1
VP
venBio Partners
California
-$9.9M
2
Franklin Resources
Franklin Resources
California
-$8.52M
3
Millennium Management
Millennium Management
New York
-$3.67M
4
Victory Capital Management
Victory Capital Management
Texas
-$1.63M
5
ACWM
Adams Chetwood Wealth Management
North Carolina
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital World Investors
1
Capital World Investors
California
$25M – – –
BlackRock
2
BlackRock
New York
$23.1M +$3.99M +20,040 +19%
ACH
3
ArrowMark Colorado Holdings
Colorado
$14.9M +$1.06M +5,347 +7%
Vanguard Group
4
Vanguard Group
Pennsylvania
$13M +$3.05M +15,342 +28%
VP
5
venBio Partners
California
$8M -$9.9M -49,780 -53%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$7.52M – – –
CA
7
CHI Advisors
New York
$6.25M +$363K +1,827 +6%
State Street
8
State Street
Massachusetts
$4.76M +$66.6K +335 +1%
WHAM
9
Windmill Hill Asset Management
United Kingdom
$4.67M +$5.03M +25,263 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$3.69M +$1.38M +6,945 +53%
Northern Trust
11
Northern Trust
Illinois
$3.26M +$291K +1,465 +9%
Principal Financial Group
12
Principal Financial Group
Iowa
$2.28M +$73K +367 +3%
WMSA
13
Weiss Multi-Strategy Advisers
New York
$2.19M -$721K -3,624 -23%
SCM
14
Sio Capital Management
New York
$2.19M +$1.13M +5,697 +92%
CAM
15
Cormorant Asset Management
Massachusetts
$2.13M – – –
ACWM
16
Adams Chetwood Wealth Management
North Carolina
$2.06M -$1.33M -6,667 -37%
IHAM
17
Integral Health Asset Management
New York
$1.85M +$1.99M +10,000 New
Charles Schwab
18
Charles Schwab
California
$1.76M +$1.04M +5,232 +122%
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$1.57M +$1.69M +8,520 New
MSAM
20
Moloney Securities Asset Management
Missouri
$1.48M +$557K +2,799 +54%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$1.46M +$1M +5,037 +176%
LCM
22
Laurion Capital Management
New York
$1.4M – – –
N
23
Nuveen
North Carolina
$1.26M +$5.57K +28 +0.4%
UBS Group
24
UBS Group
Switzerland
$1.25M +$1.25M +6,283 +1,387%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$1.07M +$60.3K +303 +6%
1
2 3 4 5

DTIL Hedge Fund Activity: Q3 2020 in Review

116 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q3 2020, worth a combined $156M — down 26% from $211M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new DTIL positions and 17 closed out — a net gain of 1 holder — while 42 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $3.99M. The largest seller was venBio Partners, cutting an estimated $9.9M.

  • 116 institutional investors held Precision BioSciences (DTIL) as of Q3 2020, up from 115 in Q2 2020.
  • Funds reported $156M of Precision BioSciences stock for Q3 2020, down 26% quarter-over-quarter.
  • 18 funds opened new Precision BioSciences positions in Q3 2020 and 17 closed out, a net change of +1 holder.
  • The largest Precision BioSciences buyer in Q3 2020 was BlackRock, an estimated $3.99M added.
  • The largest Precision BioSciences seller in Q3 2020 was venBio Partners, an estimated $9.9M sold.

Based on aggregated 13F filings for Q3 2020.